Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Talis Biomedical Q2 EPS $(8.27) Misses $(0.73) Estimate, Sales $581.00K Up From $572.00K YoY

Author: Benzinga Newsdesk | August 10, 2023 05:13pm
Talis Biomedical (NASDAQ:TLIS) reported quarterly losses of $(8.27) per share which missed the analyst consensus estimate of $(0.73) by 1032.88 percent. This is a 45.41 percent increase over losses of $(15.15) per share from the same period last year. The company reported $581.00 thousand in sales this quarter. This is a 1.57 percent increase over sales of $572.00 thousand the same period last year.

Posted In: TLIS


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist